Smith & Nephew plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Smith & Nephew plc - ADR: Is Infosys Ltd. worth buying?
Item: Smith & Nephew plc - ADR
Rating: 1.71716675
Author: Trendlyne DVM scores

about

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medici...

36.34 0.53 (1.48%)

53.40% Gain from 52W Low

605.3K

XNYS Volume

XNYS 17 Oct, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.2 / 100

Technically Moderately Bullish

60.5 / 100

1Yr Price target upside is 3%

5 analysts

Smith Nephew plc ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Smith & Nephew plc - ADR Live Stock Price Today, Share Analysis and Chart

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medici...

53.40% Gain from 52W Low

SWOT Analysis

Smith Nephew plc ADR Live Price Chart